Eight of the world’s highest dividend-paying stocks will distribute $60.7 billion to shareholders this year. Together they earned $9.8 billion above the cost of their capital. The gap determines whether the income lasts.
The number that should stop you
Eight of the world’s highest dividend-paying stocks will distribute $60.7 billion to shareholders this year. Not from an asset sale. Not from an exceptional quarter. Simply for owning the shares.
Chevron. Verizon. AbbVie. Altria. UPS. Household names, held in millions of retirement accounts. All eight are US-listed, which is less of a restriction than it sounds: the world’s largest companies are overwhelmingly American, and the biggest dividend cheques are written in dollars.
Now the figure that rarely accompanies them.
Those same eight companies, taken together, earned $9.8 billion last year above what their capital cost them. They are distributing roughly six dollars for every dollar of genuine economic profit.
Only one dollar in every six distributed is economic profit. The rest is funded elsewhere — borrowing, asset sales, depreciation charges that exceed reinvestment. If you hold these shares for income, that gap is the most important thing on this page.
The cost that never appears in the accounts
Every company runs on money belonging to someone else — shareholders, lenders, or both. That money carries a price.
If investors require a 10% return and a company earns 8% on the capital it employs, it has not made a 2% profit. It has made a 2% shortfall. Reported earnings will still be positive. Value creation will not be.
This charge appears nowhere in a set of accounts. Auditors deduct wages, interest and tax. They do not deduct the cost of capital. A business can therefore report profits for a decade while steadily making its owners poorer.
Measuring it is simple: take operating profit after tax, then subtract a charge for the capital employed. Below, that charge is 10% a year. Judged against economic profit rather than reported earnings, dividend cover looks very different.
The eight, ranked by what they earn above the cost of their capital:
1. Altria (MO) — $8.46 billion above its cost of capital, positive in all nine years. Yields 6.43%, distributing $7.06 billion.
2. AbbVie (ABBV) — $6.22 billion, positive in all nine years. Yields 2.74%, distributing $12.21 billion.
3. Bristol Myers Squibb (BMY) — $3.32 billion, positive in six of nine. Yields 3.92%, distributing $5.13 billion.
4. UPS — $3.24 billion, positive in all nine. Yields 6.26%, distributing $5.58 billion.
5. Kenvue (KVUE) — $0.41 billion, positive in two of the three years since listing. Yields 4.39%, distributing $1.61 billion.
6. Chevron (CVX) — short by $2.63 billion, positive in only three of nine. Yields 3.65%, distributing $13.97 billion.
7. Verizon (VZ) — short by $2.83 billion, positive in five of nine. Yields 5.98%, distributing $11.76 billion.
8. Duke Energy (DUK) — short by $6.42 billion, positive in none. Yields 3.50%, distributing $3.39 billion.
Together: $9.8 billion earned above the cost of capital, $60.7 billion distributed.
The second test: does the cash exist?
Economic profit is one lens. Cash is another. Compare each dividend with free cash flow — what remains after a business has paid for its own upkeep. We’ve applied the same dividend-to-free-cash-flow test to energy majors like Exxon and Occidental.
Bristol Myers Squibb is the most comfortable, distributing 40% of free cash flow. AbbVie pays 69%, Altria 78%, Chevron 84%, Kenvue 93%.
Two fail outright. UPS distributes 117% of its free cash flow — more than the business produces. Duke Energy’s free cash flow was negative before any dividend was paid at all.
Where the tests disagree is instructive. AbbVie’s dividend is comfortably covered by cash, yet nearly double its economic profit — much of that cash is consumed by the capital charge on an expensive asset base.
Only one company passes both tests. We will come to it.
The bear case, stated first
Credible analysis names the problem before it presents the answer.
Verizon is a $270 billion asset base running marginally too slow. It earns 8.8% on capital against a 10% requirement. The gap looks modest; on that base it is a $2.8 billion annual shortfall, negative four years running. The $11.76 billion dividend is covered by cash flow, not by value creation.
Duke Energy funds its dividend with debt. Last year it generated $12.33 billion from operations and invested $14.02 billion in infrastructure. Free cash flow was negative before a dollar of the $3.39 billion dividend was paid. The entire distribution was financed.
In fairness, this is Duke’s business model, not mismanagement. A regulated utility earns a return its regulator sets on an asset base funded largely with debt, so against a flat 10% charge it will always screen badly — its own cost of capital sits well below that. It is a legitimate bond substitute. The risk is mistaking it for a growth business.
Chevron requires a longer lens. It is short $2.63 billion this year, but energy is cyclical. Its three-year average is positive at $2.81 billion, its five-year at $5.90 billion.
The one company that earns its dividend
The business at the top of that ranking is the one the market is least comfortable discussing.
Altria generated $8.46 billion above its cost of capital last year and distributed $7.06 billion — a ratio of 83%.
It is the only company here funding its dividend from genuine economic profit rather than the balance sheet, nine years out of nine, and the only one to pass the cash test alongside it. Its return on capital is 44%, more than double the next best.
The valuation is the interesting part. At today’s price the market implies 4.4% growth in perpetuity — roughly the pace of the economy, from a business earning 44% on its capital.
That is not irrational. Cigarette volumes decline every year, litigation is permanent, regulatory risk unresolved. Those concerns are legitimate, and precisely why the shares trade where they do.
But a business in decline and a business that cannot fund its dividend are not the same thing. Altria is plainly the former. On these figures it is not yet the latter — and that distinction is where income investors are made or unmade.
The remainder of the field
AbbVie is the quality name here, and the market knows it — pricing in 8.1% growth in perpetuity, nearly double the economy’s pace, sustained indefinitely. That is what the lowest yield on the list buys you.
Bristol Myers Squibb has the strongest cash cover of any name here, despite excess profit swinging to negative $12.3 billion in 2024. UPS has watched its own more than halve since 2021. Kenvue passes, with very little margin.
What the numbers demonstrate
AbbVie has the lowest yield on the list, 2.74%, and the second-strongest economics. Chevron writes the largest cheque, $13.97 billion, and earned nothing above its cost of capital last year.
Yield conveyed no information about quality.
A high yield is not a reward. It is a price, high because the market has reservations — occasionally unfounded, more often justified. A 6% yield in a market yielding roughly 1% says plainly that the payment is not expected to persist.
The market is sometimes wrong, and that is where returns are earned. But those situations are found in the accounts, not by ranking a screen from highest yield down.
Three Tests Before You Buy the Highest Dividend-Paying Stocks
Is the dividend funded by profit or by borrowing? Compare it to free cash flow, not reported earnings. Earnings are open to presentation; cash is harder to manage.
Does the company earn more than its capital costs? If not, every increment of growth makes shareholders poorer, however dependable the payment looks.
What does the price already assume? Every share price contains a forecast. AbbVie’s requires 8.1% growth a year, indefinitely; Altria’s requires 4.4%. AbbVie must clear the higher bar for you merely to break even. Altria only has to avoid collapse. A low yield on an excellent business can therefore carry more risk than a high yield on a declining one — the quality is already paid for.
Three of these eight destroy value at a 10% required return. That does not make them uninvestable — a declining business that pays generously can be sound at the right price.
What matters is knowing which one you own. The dividend will not disclose it. The accounts will. For a broader look at dividend stocks worth buying beyond this list of eight, see our full ranking.
Analysis, not investment advice. Figures come from published financial statements and declared dividend rates as at 13 August 2026, measured against a 10% required return on net operating assets, stated unlevered. Universe: US-listed large caps. Dividends may be cut at any time. Do your own research, or consult a licensed adviser, before investing.
FAQs
Which stock has the highest dividend yield in the world?
Among widely held large-cap stocks, Chevron and Verizon offer some of the highest yields — 3.65% and 5.98% respectively — though a high yield alone doesn’t confirm the dividend is sustainable.
What is a good dividend yield for a stock?
A “good” yield depends on the sector, but generally 3–6% is considered healthy for stable, blue-chip companies. Yields above 6–7% often signal market concern about the dividend’s safety, not just generosity.
Can a company pay dividends without making a profit?
Yes — companies can fund dividends through borrowing, asset sales, or excess cash reserves even when profits don’t cover the payout. This is common in capital-intensive sectors like utilities and energy.
How do you know if a dividend is safe?
Compare the dividend to free cash flow (not just earnings) and check if the company earns more than its cost of capital. If the payout ratio exceeds 100% of free cash flow, the dividend may not be sustainable long-term.
What is the safest dividend stock to buy?
There’s no universally “safest” stock, but investors typically look for companies with consistent free cash flow coverage, positive economic profit, and a history of maintaining — not just growing — the dividend through economic
